DXCM analyst estimates
DexCom (DXCM) analyst ratings, the average price target and its range, and every firm's latest call.
DXCM analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 30, 2026 | Raymond James | DexCom (DXCM) PT Raised to $97 at Raymond James | $97.00 |
| Oct 13, 2026 | Mizuho Securities | DexCom price target raised to $100 from $95 at Mizuho | $100.00 |
| Oct 6, 2026 | Barclays | DexCom initiated with an Overweight at Barclays | $115.00 |
| Oct 1, 2026 | RBC Capital | DexCom price target raised to $105 from $90 at RBC Capital | $105.00 |
| Sep 18, 2026 | Truist Financial | DexCom price target raised to $102 from $93 at Truist | $102.00 |
| Aug 4, 2026 | Argus Research | DexCom price target raised to $96 from $86 at Argus | $96.00 |
| Aug 3, 2026 | RBC Capital | DexCom (DXCM) PT Raised to $90 at Canaccord | $90.00 |
| Aug 3, 2026 | Canaccord Genuity | DexCom price target raised to $90 from $82 at Canaccord | $90.00 |
| Jul 31, 2026 | Stifel Nicolaus | DexCom (DXCM) PT Raised to $95 at Stifel | $95.00 |
| Jul 31, 2026 | Truist Financial | DexCom (DXCM) PT Raised to $93 at Truist Securities | $93.00 |
| Jul 31, 2026 | BTIG | DexCom (DXCM) PT Raised to $90 at BTIG | $90.00 |
| Jul 31, 2026 | Robert W. Baird | DexCom price target raised to $105 from $80 at Baird | $105.00 |
| Jul 31, 2026 | Piper Sandler | DexCom price target raised to $95 from $88 at Piper Sandler | $95.00 |
| Jul 31, 2026 | Raymond James | DexCom price target raised to $94 from $91 at Raymond James | $94.00 |
| Jul 28, 2026 | UBS | DexCom resumed with a Buy at UBS | $96.00 |
- 21 firms rate DXCM: 19 buy, 2 hold, 0 sell.
- The average price target is $98.83 from 12 analysts, from $90.00 to $115.00.
Updated 2026-11-02 17:51 UTC